Annual EBIT:
$583.00M+$246.30M(+73.15%)Summary
- As of today, NBIX annual earnings before interest & taxes is $583.00 million, with the most recent change of +$246.30 million (+73.15%) on December 31, 2024.
- During the last 3 years, NBIX annual EBIT has risen by +$455.80 million (+358.33%).
- NBIX annual EBIT is now at all-time high.
Performance
NBIX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
$145.60M+$121.90M(+514.35%)Summary
- As of today, NBIX quarterly earnings before interest & taxes is $145.60 million, with the most recent change of +$121.90 million (+514.35%) on June 30, 2025.
- Over the past year, NBIX quarterly EBIT has dropped by -$2.30 million (-1.56%).
- NBIX quarterly EBIT is now -21.21% below its all-time high of $184.80 million, reached on September 30, 2024.
Performance
NBIX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
$528.70M-$2.30M(-0.43%)Summary
- As of today, NBIX TTM earnings before interest & taxes is $528.70 million, with the most recent change of -$2.30 million (-0.43%) on June 30, 2025.
- Over the past year, NBIX TTM EBIT has dropped by -$16.00 million (-2.94%).
- NBIX TTM EBIT is now -13.70% below its all-time high of $612.60 million, reached on December 31, 2024.
Performance
NBIX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
NBIX EBIT Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1Y1 Year | +73.2% | -1.6% | -2.9% |
3Y3 Years | +358.3% | +790.0% | +1511.9% |
5Y5 Years | +642.7% | +59.1% | +286.5% |
NBIX EBIT Highs & Lows
PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
---|---|---|---|---|---|---|---|
3Y | 3-Year | at high | +358.3% | -21.2% | +242.5% | -13.7% | +457.7% |
5Y | 5-Year | at high | +642.7% | -21.2% | +242.5% | -13.7% | +1511.9% |
All-Time | All-Time | at high | +374.7% | -21.2% | +213.2% | -13.7% | +345.8% |
NBIX EBIT History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | $145.60M(+514.3%) | $528.70M(-0.4%) |
Mar 2025 | - | $23.70M(-86.4%) | $531.00M(-13.3%) |
Dec 2024 | $583.00M(+73.2%) | $174.60M(-5.5%) | $612.60M(+4.1%) |
Sep 2024 | - | $184.80M(+24.9%) | $588.30M(+8.0%) |
Jun 2024 | - | $147.90M(+40.5%) | $544.70M(+15.8%) |
Mar 2024 | - | $105.30M(-29.9%) | $470.40M(+78.9%) |
Dec 2023 | $336.70M(+52.4%) | $150.30M(+6.4%) | $262.90M(+1.3%) |
Sep 2023 | - | $141.20M(+91.8%) | $259.60M(+19.4%) |
Jun 2023 | - | $73.60M(+172.0%) | $217.50M(+77.1%) |
Mar 2023 | - | -$102.20M(-169.5%) | $122.80M(-50.7%) |
Dec 2022 | $221.00M(+73.7%) | $147.00M(+48.3%) | $249.00M(+162.7%) |
Sep 2022 | - | $99.10M(+569.7%) | $94.80M(+189.0%) |
Jun 2022 | - | -$21.10M(-187.9%) | $32.80M(-72.1%) |
Mar 2022 | - | $24.00M(+433.3%) | $117.60M(-7.5%) |
Dec 2021 | $127.20M(-8.8%) | -$7.20M(-119.4%) | $127.20M(-30.8%) |
Sep 2021 | - | $37.10M(-41.8%) | $183.90M(+87.3%) |
Jun 2021 | - | $63.70M(+89.6%) | $98.20M(-22.1%) |
Mar 2021 | - | $33.60M(-32.1%) | $126.00M(-9.7%) |
Dec 2020 | $139.50M(+77.7%) | $49.50M(+201.9%) | $139.50M(+2.0%) |
Sep 2020 | - | -$48.60M(-153.1%) | $136.80M(-45.7%) |
Jun 2020 | - | $91.50M(+94.3%) | $251.80M(+14.3%) |
Mar 2020 | - | $47.10M(+0.6%) | $220.30M(+180.6%) |
Dec 2019 | $78.50M(+50.1%) | $46.80M(-29.5%) | $78.50M(+34.9%) |
Sep 2019 | - | $66.40M(+10.7%) | $58.20M(+15.9%) |
Jun 2019 | - | $60.00M(+163.4%) | $50.24M(+721.3%) |
Mar 2019 | - | -$94.70M(-457.4%) | -$8.09M(-115.5%) |
Dec 2018 | $52.30M(+142.5%) | $26.50M(-54.7%) | $52.30M(+30.4%) |
Sep 2018 | - | $58.44M(+3382.5%) | $40.11M(+281.4%) |
Jun 2018 | - | $1.68M(+104.9%) | -$22.11M(+72.0%) |
Mar 2018 | - | -$34.31M(-339.7%) | -$79.01M(+35.8%) |
Dec 2017 | -$123.02M(+12.8%) | $14.31M(+477.9%) | -$123.02M(+32.4%) |
Sep 2017 | - | -$3.79M(+93.1%) | -$181.99M(+15.4%) |
Jun 2017 | - | -$55.22M(+29.5%) | -$215.09M(-7.5%) |
Mar 2017 | - | -$78.33M(-75.4%) | -$200.15M(-40.3%) |
Dec 2016 | -$141.09M(-58.7%) | -$44.66M(-21.1%) | -$142.68M(-15.5%) |
Sep 2016 | - | -$36.89M(+8.4%) | -$123.50M(-0.9%) |
Jun 2016 | - | -$40.28M(-93.1%) | -$122.46M(-13.9%) |
Mar 2016 | - | -$20.86M(+18.1%) | -$107.50M(-20.9%) |
Dec 2015 | -$88.93M(-38.1%) | -$25.48M(+28.9%) | -$88.93M(-6.0%) |
Sep 2015 | - | -$35.84M(-41.6%) | -$83.92M(-29.2%) |
Jun 2015 | - | -$25.32M(-1006.7%) | -$64.94M(-20.3%) |
Mar 2015 | - | -$2.29M(+88.8%) | -$53.97M(+16.2%) |
Dec 2014 | -$64.41M(-29.7%) | -$20.47M(-21.4%) | -$64.41M(-16.1%) |
Sep 2014 | - | -$16.86M(-17.4%) | -$55.47M(-9.6%) |
Jun 2014 | - | -$14.36M(-12.9%) | -$50.62M(-2.4%) |
Mar 2014 | - | -$12.72M(-10.4%) | -$49.43M(+0.5%) |
Dec 2013 | -$49.68M(-3530.8%) | -$11.53M(+4.0%) | -$49.68M(-68.0%) |
Sep 2013 | - | -$12.01M(+8.8%) | -$29.57M(-37.4%) |
Jun 2013 | - | -$13.17M(-1.5%) | -$21.52M(-121.1%) |
Mar 2013 | - | -$12.97M(-251.2%) | -$9.73M(-772.3%) |
Dec 2012 | $1.45M(-95.7%) | $8.58M(+316.6%) | $1.45M(+121.7%) |
Sep 2012 | - | -$3.96M(-187.1%) | -$6.69M(-124.1%) |
Jun 2012 | - | -$1.38M(+23.0%) | $27.71M(-8.2%) |
Mar 2012 | - | -$1.79M(-500.9%) | $30.19M(-11.0%) |
Dec 2011 | $33.92M(+347.2%) | $447.00K(-98.5%) | $33.92M(+1.7%) |
Sep 2011 | - | $30.44M(+2677.4%) | $33.35M(+520.7%) |
Jun 2011 | - | $1.10M(-43.5%) | $5.37M(+432.8%) |
Mar 2011 | - | $1.94M(+1603.1%) | -$1.61M(+88.2%) |
Dec 2010 | -$13.72M | -$129.00K(-105.2%) | -$13.72M(+47.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2010 | - | $2.47M(+141.9%) | -$25.87M(+31.9%) |
Jun 2010 | - | -$5.89M(+42.1%) | -$37.97M(+19.2%) |
Mar 2010 | - | -$10.17M(+17.2%) | -$46.99M(+8.1%) |
Dec 2009 | -$51.11M(+37.4%) | -$12.28M(-27.5%) | -$51.11M(+19.9%) |
Sep 2009 | - | -$9.63M(+35.4%) | -$63.84M(+8.7%) |
Jun 2009 | - | -$14.90M(-4.2%) | -$69.91M(+6.9%) |
Mar 2009 | - | -$14.30M(+42.8%) | -$75.12M(+7.9%) |
Dec 2008 | -$81.59M(+61.6%) | -$25.00M(-59.2%) | -$81.59M(+55.9%) |
Sep 2008 | - | -$15.70M(+21.9%) | -$185.18M(+6.6%) |
Jun 2008 | - | -$20.12M(+3.1%) | -$198.30M(+3.6%) |
Mar 2008 | - | -$20.76M(+83.9%) | -$205.73M(+3.1%) |
Dec 2007 | -$212.24M(-87.3%) | -$128.59M(-346.1%) | -$212.24M(-112.4%) |
Sep 2007 | - | -$28.83M(-4.6%) | -$99.91M(+10.2%) |
Jun 2007 | - | -$27.55M(-1.0%) | -$111.28M(+1.5%) |
Mar 2007 | - | -$27.27M(-67.7%) | -$113.00M(+0.3%) |
Dec 2006 | -$113.32M(-352.0%) | -$16.26M(+59.5%) | -$113.32M(+6.8%) |
Sep 2006 | - | -$40.20M(-37.4%) | -$121.65M(-116.0%) |
Jun 2006 | - | -$29.26M(-6.1%) | -$56.33M(-69.1%) |
Mar 2006 | - | -$27.59M(-12.2%) | -$33.32M(-32.9%) |
Dec 2005 | -$25.07M(+52.1%) | -$24.59M(-197.9%) | -$25.07M(-15.7%) |
Sep 2005 | - | $25.12M(+501.8%) | -$21.66M(+56.5%) |
Jun 2005 | - | -$6.25M(+67.7%) | -$49.81M(+12.5%) |
Mar 2005 | - | -$19.35M(+8.7%) | -$56.95M(-8.8%) |
Dec 2004 | -$52.33M(+11.0%) | -$21.18M(-598.9%) | -$52.33M(-7.9%) |
Sep 2004 | - | -$3.03M(+77.4%) | -$48.52M(+17.9%) |
Jun 2004 | - | -$13.39M(+9.1%) | -$59.06M(-1.5%) |
Mar 2004 | - | -$14.73M(+15.2%) | -$58.16M(+1.1%) |
Dec 2003 | -$58.79M(+43.3%) | -$17.37M(-28.0%) | -$58.79M(+28.9%) |
Sep 2003 | - | -$13.57M(-8.7%) | -$82.69M(+9.7%) |
Jun 2003 | - | -$12.49M(+18.6%) | -$91.62M(+9.4%) |
Mar 2003 | - | -$15.35M(+62.8%) | -$101.15M(+2.4%) |
Dec 2002 | -$103.61M(-136.1%) | -$41.27M(-83.4%) | -$103.61M(-33.3%) |
Sep 2002 | - | -$22.50M(-2.2%) | -$77.75M(-43.8%) |
Jun 2002 | - | -$22.02M(-23.6%) | -$54.05M(-13.5%) |
Mar 2002 | - | -$17.82M(-15.7%) | -$47.62M(-8.5%) |
Dec 2001 | -$43.88M(-23.3%) | -$15.40M(-1391.2%) | -$43.88M(-10.3%) |
Sep 2001 | - | $1.19M(+107.7%) | -$39.79M(+21.5%) |
Jun 2001 | - | -$15.59M(-10.7%) | -$50.67M(-19.3%) |
Mar 2001 | - | -$14.08M(-24.5%) | -$42.45M(-19.2%) |
Dec 2000 | -$35.60M(-78.9%) | -$11.31M(-16.8%) | -$35.60M(-21.5%) |
Sep 2000 | - | -$9.69M(-31.2%) | -$29.29M(-19.0%) |
Jun 2000 | - | -$7.38M(-2.1%) | -$24.61M(-9.3%) |
Mar 2000 | - | -$7.23M(-44.5%) | -$22.52M(-13.8%) |
Dec 1999 | -$19.90M(-60.5%) | -$5.00M(0.0%) | -$19.79M(-7.0%) |
Sep 1999 | - | -$5.00M(+5.5%) | -$18.49M(-11.5%) |
Jun 1999 | - | -$5.29M(-17.6%) | -$16.59M(-12.9%) |
Mar 1999 | - | -$4.50M(-21.6%) | -$14.70M(-16.7%) |
Dec 1998 | -$12.40M(-2580.0%) | -$3.70M(-19.4%) | -$12.60M(-23.5%) |
Sep 1998 | - | -$3.10M(+8.8%) | -$10.20M(-36.0%) |
Jun 1998 | - | -$3.40M(-41.7%) | -$7.50M(-50.0%) |
Mar 1998 | - | -$2.40M(-84.6%) | -$5.00M(-933.3%) |
Dec 1997 | $500.00K(-82.8%) | -$1.30M(-225.0%) | $600.00K(-88.5%) |
Sep 1997 | - | -$400.00K(+55.6%) | $5.20M(+26.8%) |
Jun 1997 | - | -$900.00K(-128.1%) | $4.10M(-34.9%) |
Mar 1997 | - | $3.20M(-3.0%) | $6.30M(+117.2%) |
Dec 1996 | $2.90M | $3.30M(+320.0%) | $2.90M(+825.0%) |
Sep 1996 | - | -$1.50M(-215.4%) | -$400.00K(-136.4%) |
Jun 1996 | - | $1.30M(+750.0%) | $1.10M(+650.0%) |
Mar 1996 | - | -$200.00K | -$200.00K |
FAQ
- What is Neurocrine Biosciences, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Neurocrine Biosciences, Inc.?
- What is Neurocrine Biosciences, Inc. annual EBIT year-on-year change?
- What is Neurocrine Biosciences, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Neurocrine Biosciences, Inc.?
- What is Neurocrine Biosciences, Inc. quarterly EBIT year-on-year change?
- What is Neurocrine Biosciences, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Neurocrine Biosciences, Inc.?
- What is Neurocrine Biosciences, Inc. TTM EBIT year-on-year change?
What is Neurocrine Biosciences, Inc. annual earnings before interest & taxes?
The current annual EBIT of NBIX is $583.00M
What is the all-time high annual EBIT for Neurocrine Biosciences, Inc.?
Neurocrine Biosciences, Inc. all-time high annual earnings before interest & taxes is $583.00M
What is Neurocrine Biosciences, Inc. annual EBIT year-on-year change?
Over the past year, NBIX annual earnings before interest & taxes has changed by +$246.30M (+73.15%)
What is Neurocrine Biosciences, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of NBIX is $145.60M
What is the all-time high quarterly EBIT for Neurocrine Biosciences, Inc.?
Neurocrine Biosciences, Inc. all-time high quarterly earnings before interest & taxes is $184.80M
What is Neurocrine Biosciences, Inc. quarterly EBIT year-on-year change?
Over the past year, NBIX quarterly earnings before interest & taxes has changed by -$2.30M (-1.56%)
What is Neurocrine Biosciences, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of NBIX is $528.70M
What is the all-time high TTM EBIT for Neurocrine Biosciences, Inc.?
Neurocrine Biosciences, Inc. all-time high TTM earnings before interest & taxes is $612.60M
What is Neurocrine Biosciences, Inc. TTM EBIT year-on-year change?
Over the past year, NBIX TTM earnings before interest & taxes has changed by -$16.00M (-2.94%)